Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536841) titled 'Ambispective Validation of the Odesa Criteria 2026 (OC26): A Flexible Point-Based System for Diagnosis of Autoimmune Pancreatitis' on April 11.
Study Type: Observational
Primary Sponsor: Military Medical Clinical Center of the Southern Region, Ukraine
Condition:
Autoimmune Pancreatitis
IgG4-Related Diseases
Pancreatic Cancer
Chronic Pancreatitis
Recruitment Status: Not recruiting
Date of First Enrollment: May 1, 2026
Target Sample Size: 82
To know more, visit https://clinicaltrials.gov/study/NCT07536841
Published by HT Digital Content Services with permission from Health Daily Digest....